U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

Search Names Beginning with 1

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Maximum Daily Exposure (MDE) Record Updated
1-(PHENYLAZO)-2-NAPHTHYLAMINE ORAL CAPSULE 85847 3VSI4D701X 0.13mg
1-(PHENYLAZO)-2-NAPHTHYLAMINE ORAL TABLET 85847 3VSI4D701X 0.2mg
1,2,6-HEXANETRIOL TOPICAL CREAM 106694 W45XXM0XWE 43mg
1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE INTRAVENOUS INJECTABLE, LIPOSOMAL 816944 043IPI2M0K 2.8%w/v
1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE INTRAVENOUS INJECTION 816944 043IPI2M0K 68mg
1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE RESPIRATORY (INHALATION) CAPSULE 816944 043IPI2M0K 51mg
1,4-SORBITAN ORAL CAPSULE 27299123 AV0YTZ4E6J 242mg

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: January 1, 2023
Database Last Updated: January 26, 2023

Back to Top